ULIPRISTAL ACETATE (UPA) IS AFFORDABLE AS EMERGENCY CONTRACEPTION (EC) IF USED WHERE LEVONORGESTREL (LNG) IS UNLICENSED

被引：0
|
作者：
Jones, A. B. [1 ]
Garcia, L. Dominguez [1 ]
Cohen, C. E. [1 ]
Nwokolo, N. [1 ]
Day, S. L. [1 ]
机构：
[1] Chelsea & Westminster Hosp, London, England
来源：
SEXUALLY TRANSMITTED INFECTIONS | 2012年 / 88卷
关键词：
D O I：
10.1136/sextrans-2012-050601c.88
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [41] Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel
    Edelman, Alison
    Jensen, Jeffrey T.
    Brown, Jill
    Thomas, Michael
    Archer, David F.
    Schreiber, Courtney A.
    Teal, Stephanie
    Westhoff, Carolyn
    Dart, Clint
    Blithe, Diana L.
    CONTRACEPTION, 2024, 137
  • [42] Availability of ulipristal acetate: A secret shopper survey of pharmacies in a metropolitan area on emergency contraception
    French, Valerie A.
    Mattingly, Tateum L.
    Rangel, Ariana V.
    Shelton, Annie U.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2019, 59 (06) : 832 - 835
  • [43] Can We Identify Women at Risk of Pregnancy Despite Using Emergency Contraception? Data From Randomized Trials of Ulipristal Acetate and Levonorgestrel EDITORIAL COMMENT
    Glasier, Anna
    Cameron, Sharon T.
    Blithe, Diana
    Scherrer, Bruno
    Mathe, Henri
    Levy, Delphine
    Gainer, Erin
    Ulmann, Andre
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2013, 68 (03) : 208 - 210
  • [44] The rationale for use of Ulipristal Acetate as first line in emergency contraception: biological and clinical evidence
    Glasier, Anna
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (10) : 688 - 690
  • [45] Pregnancy Outcomes Following Ulipristal Acetate Emergency Contraception Failure: A Report of Five Cases
    Ozturk, Zeynep
    Akgul, Emine
    FETAL AND PEDIATRIC PATHOLOGY, 2017, 36 (03) : 213 - 219
  • [46] Ulipristal Acetate Taken 48-120 Hours After Intercourse for Emergency Contraception
    Fine, Paul
    Mathe, Henri
    Ginde, Savita
    Cullins, Vanessa
    Morfesis, Johanna
    Gainer, Erin
    OBSTETRICS AND GYNECOLOGY, 2010, 115 (02): : 257 - 263
  • [47] Emergency contraception failure and ulipristal acetate exposure in pregnant women: First concerns and outcomes
    Ozturk, Z.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S75 - S76
  • [48] Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis (vol 375, pg 555, 2010)
    Glasier, A. F.
    Cameron, S. T.
    Fine, P. M.
    LANCET, 2014, 384 (9953): : 1504 - 1504
  • [49] Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial
    Edelman, Alison
    Hennebold, Jon D.
    Bond, Kise
    Lim, Jeong Y.
    Cherala, Ganesh
    Blue, Steven W.
    Kraft, Shawn P.
    Erikson, David W.
    Archer, David
    Jensen, Jeffery
    BMJ SEXUAL & REPRODUCTIVE HEALTH, 2024,
  • [50] Drug points - Apparent interaction between warfarin and levonorgestrel used for emergency contraception
    Ellison, J
    Thomson, AJ
    Greer, IA
    Walker, ID
    BRITISH MEDICAL JOURNAL, 2000, 321 (7273): : 1382 - 1382
12345